title: Physicians' perceptions of the benefits and risks of warfarin for patients with nonvalvular atrial fibrillation.
authors.forename: T J
authors.initials: TJ
authors.lastname: Bungard
authors.forename: W A
authors.initials: WA
authors.lastname: Ghali
authors.forename: F A
authors.initials: FA
authors.lastname: McAlister
authors.forename: A M
authors.initials: AM
authors.lastname: Buchan
authors.forename: A J
authors.initials: AJ
authors.lastname: Cave
authors.forename: P G
authors.initials: PG
authors.lastname: Hamilton
authors.forename: L B
authors.initials: LB
authors.lastname: Mitchell
authors.forename: A
authors.initials: A
authors.lastname: Shuaib
authors.forename: K K
authors.initials: KK
authors.lastname: Teo
authors.forename: R T
authors.initials: RT
authors.lastname: Tsuyuki
mesh_terms: D000416:Alberta; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001291:Attitude of Health Personnel; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D010820:Physicians / Q000523:psychology*; D012306:Risk; D020521:Stroke / Q000517:prevention & control; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin